PubMed:32559589
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 36-47 | CHEBI:3638 | denotes | chloroquine |
T2 | 36-47 | DG_10 | denotes | chloroquine |
T3 | 36-47 | CHEBI:3638 | denotes | chloroquine |
T4 | 51-69 | CHEBI:5801 | denotes | hydroxychloroquine |
T5 | 51-69 | DG_20 | denotes | hydroxychloroquine |
T6 | 51-69 | CHEBI:5801 | denotes | hydroxychloroquine |
T7 | 82-90 | SP_7 | denotes | COVID-19 |
T8 | 94-101 | NCBITaxon:1 | denotes | persons |
T9 | 224-235 | CHEBI:3638 | denotes | chloroquine |
T10 | 224-235 | DG_10 | denotes | chloroquine |
T11 | 224-235 | CHEBI:3638 | denotes | chloroquine |
T12 | 239-257 | CHEBI:5801 | denotes | hydroxychloroquine |
T13 | 239-257 | DG_20 | denotes | hydroxychloroquine |
T14 | 239-257 | CHEBI:5801 | denotes | hydroxychloroquine |
T15 | 269-276 | NCBITaxon:1 | denotes | persons |
T16 | 313-321 | SP_7 | denotes | COVID-19 |
T17 | 384-394 | SP_7 | denotes | SARS CoV-2 |
T18 | 395-400 | NCBITaxon:10239 | denotes | virus |
T19 | 402-413 | CHEBI:3638 | denotes | Chloroquine |
T20 | 402-413 | DG_10 | denotes | Chloroquine |
T21 | 402-413 | CHEBI:3638 | denotes | Chloroquine |
T22 | 417-435 | CHEBI:5801 | denotes | hydroxychloroquine |
T23 | 417-435 | DG_20 | denotes | hydroxychloroquine |
T24 | 417-435 | CHEBI:5801 | denotes | hydroxychloroquine |
T25 | 532-538 | SO:0000667 | denotes | insert |
T26 | 557-568 | CHEBI:23888 | denotes | medications |
T27 | 557-568 | CHEBI:23888 | denotes | medications |
T28 | 811-822 | CHEBI:3638 | denotes | chloroquine |
T29 | 811-822 | DG_10 | denotes | chloroquine |
T30 | 811-822 | CHEBI:3638 | denotes | chloroquine |
T31 | 826-844 | CHEBI:5801 | denotes | hydroxychloroquine |
T32 | 826-844 | DG_20 | denotes | hydroxychloroquine |
T33 | 826-844 | CHEBI:5801 | denotes | hydroxychloroquine |
T34 | 954-958 | CHEBI:23888 | denotes | drug |
T35 | 954-958 | CHEBI:23888 | denotes | drug |
T36 | 1073-1084 | CHEBI:3638 | denotes | chloroquine |
T37 | 1073-1084 | DG_10 | denotes | chloroquine |
T38 | 1073-1084 | CHEBI:3638 | denotes | chloroquine |
T39 | 1199-1210 | CHEBI:3638 | denotes | chloroquine |
T40 | 1199-1210 | DG_10 | denotes | chloroquine |
T41 | 1199-1210 | CHEBI:3638 | denotes | chloroquine |
T42 | 1314-1332 | CHEBI:5801 | denotes | hydroxychloroquine |
T43 | 1314-1332 | DG_20 | denotes | hydroxychloroquine |
T44 | 1314-1332 | CHEBI:5801 | denotes | hydroxychloroquine |
T45 | 1491-1502 | CHEBI:3638 | denotes | chloroquine |
T46 | 1491-1502 | DG_10 | denotes | chloroquine |
T47 | 1491-1502 | CHEBI:3638 | denotes | chloroquine |
T48 | 1506-1524 | CHEBI:5801 | denotes | hydroxychloroquine |
T49 | 1506-1524 | DG_20 | denotes | hydroxychloroquine |
T50 | 1506-1524 | CHEBI:5801 | denotes | hydroxychloroquine |
T51 | 1559-1565 | SO:0000667 | denotes | insert |
T52 | 1880-1891 | CHEBI:23888 | denotes | medications |
T53 | 1880-1891 | CHEBI:23888 | denotes | medications |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 82-90 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 107-115 | Disease | denotes | epilepsy | http://purl.obolibrary.org/obo/MONDO_0005027 |
T3 | 294-302 | Disease | denotes | epilepsy | http://purl.obolibrary.org/obo/MONDO_0005027 |
T4 | 313-321 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 384-388 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 607-615 | Disease | denotes | epilepsy | http://purl.obolibrary.org/obo/MONDO_0005027 |
T7 | 666-673 | Disease | denotes | anxiety | http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918 |
T9 | 681-689 | Disease | denotes | epilepsy | http://purl.obolibrary.org/obo/MONDO_0005027 |
T10 | 860-868 | Disease | denotes | epilepsy | http://purl.obolibrary.org/obo/MONDO_0005027 |
T11 | 886-904 | Disease | denotes | status epilepticus | http://purl.obolibrary.org/obo/MONDO_0002125 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 341-342 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 395-400 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T3 | 468-471 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T4 | 626-629 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T5 | 732-734 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T6 | 772-774 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T7 | 1269-1270 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 1649-1650 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 36-47 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T2 | 51-69 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T3 | 224-235 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T4 | 239-257 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T5 | 402-413 | Chemical | denotes | Chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T6 | 417-435 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T7 | 811-822 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T8 | 826-844 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T9 | 954-958 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T10 | 1073-1084 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T11 | 1199-1210 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T12 | 1314-1332 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T13 | 1491-1502 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T14 | 1506-1524 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-116 | Sentence | denotes | Assessing the risk of seizures with chloroquine or hydroxychloroquine therapy for COVID-19 in persons with epilepsy. |
T2 | 117-128 | Sentence | denotes | BACKGROUND: |
T3 | 129-303 | Sentence | denotes | The goal of this systematic review is to assess the published literature for seizure risk with chloroquine or hydroxychloroquine therapy in persons with and without epilepsy. |
T4 | 304-401 | Sentence | denotes | With the COVID-19 pandemic, there is a desperate need for treatment against the SARS CoV-2 virus. |
T5 | 402-510 | Sentence | denotes | Chloroquine or hydroxychloroquine is one proposed medication that has received substantial public attention. |
T6 | 511-700 | Sentence | denotes | However, the package insert states that these medications may provoke seizures in patients with epilepsy, and this has resulted in increased questions and anxiety in the epilepsy community. |
T7 | 701-709 | Sentence | denotes | METHODS: |
T8 | 710-905 | Sentence | denotes | PubMed (1970 to March 27, 2020) and the Embase (1970 to March 27, 2020) were searched with the terms chloroquine or hydroxychloroquine and seizure or epilepsy, convulsions, or status epilepticus. |
T9 | 906-983 | Sentence | denotes | Selected studies were reviewed, and the adverse drug reaction was classified. |
T10 | 984-992 | Sentence | denotes | RESULTS: |
T11 | 993-1068 | Sentence | denotes | Only eleven out of 31 studies were deemed eligible for systematic analysis. |
T12 | 1069-1186 | Sentence | denotes | For chloroquine, eligible studies were- one prospective study(n = 109), two case series(n = 6), and six case reports. |
T13 | 1187-1309 | Sentence | denotes | The dose of chloroquine ranged between 100-500 mg/day, except in one patient with a seizure, who was after taking 1000 mg. |
T14 | 1310-1409 | Sentence | denotes | For hydroxychloroquine, there was one prospective observational study(n = 631) and one case report. |
T15 | 1410-1525 | Sentence | denotes | The clinical trials failed to find any significant relation between seizures and chloroquine or hydroxychloroquine. |
T16 | 1526-1537 | Sentence | denotes | CONCLUSION: |
T17 | 1538-1698 | Sentence | denotes | Although the package insert describes an increased risk of seizure, the systematic review highlights that such a statement is not supported by class I evidence. |
T18 | 1699-1824 | Sentence | denotes | Clinicians, therefore, need to understand that data regarding this specific topic is limited to case series and case reports. |
T19 | 1825-1918 | Sentence | denotes | There is no substantial evidence to suggest that these medications can increase seizure risk. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 22-30 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T2 | 107-115 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T3 | 206-213 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T4 | 294-302 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T5 | 581-589 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T6 | 607-615 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T7 | 666-673 | Phenotype | denotes | anxiety | http://purl.obolibrary.org/obo/HP_0000739 |
T8 | 681-689 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T9 | 849-856 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T10 | 860-868 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T11 | 870-904 | Phenotype | denotes | convulsions, or status epilepticus | http://purl.obolibrary.org/obo/HP_0032660 |
T12 | 946-967 | Phenotype | denotes | adverse drug reaction | http://purl.obolibrary.org/obo/HP_0020172 |
T13 | 1271-1278 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T14 | 1478-1486 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T15 | 1597-1604 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T16 | 1905-1912 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
hydroxychloroquine
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 22-30 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T2 | 107-115 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T3 | 206-213 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T4 | 294-302 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T5 | 581-589 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T6 | 607-615 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T7 | 666-673 | Phenotype | denotes | anxiety | http://purl.obolibrary.org/obo/HP_0000739 |
T8 | 681-689 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T9 | 849-856 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T10 | 860-868 | Phenotype | denotes | epilepsy | http://purl.obolibrary.org/obo/HP_0001250 |
T11 | 870-904 | Phenotype | denotes | convulsions, or status epilepticus | http://purl.obolibrary.org/obo/HP_0032660 |
T12 | 946-967 | Phenotype | denotes | adverse drug reaction | http://purl.obolibrary.org/obo/HP_0020172 |
T13 | 1271-1278 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T14 | 1478-1486 | Phenotype | denotes | seizures | http://purl.obolibrary.org/obo/HP_0001250 |
T15 | 1597-1604 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |
T16 | 1905-1912 | Phenotype | denotes | seizure | http://purl.obolibrary.org/obo/HP_0001250 |